On performing multivariable regression analysis, we identified that the baseline FGF-23 (adjusted odds ratio (aOR): 2.87, 95% confidence interval (CI): 1.47, 5.62), eGFRcr-cys (aOR: 2.50, 95% CI: 1.54, 4.05), urine albumin-creatinine ratio (UACR) (aOR: 1.16, 95% CI: 1.03, 1.32), and central obesity (aOR: 5.09, 95% CI: 1.15, 22.60) had independent prognostic significance for the likelihood of RKFD (Table 2). The gene discussed is FGF23; the disease is Abdominal obesity.